Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.


Local Girls Recognized By The American Lung Association For Outstanding Achievements

The American Lung Association in Tennessee will be recognizing the work of five local scholars, published authors, and accomplished philanthropists next month. But these women haven't had a lifetime to build their success. They haven't even graduated from high school yet.  The ALA Young Women of Distinction Award is offered each year to high school seniors who set themselves ... (click for more)

Alexander, Murray Introduce Budget Amendment For Medical Treatments To Reach American Patients

Senate health committee Chairman Lamar Alexander and Ranking Member Patty Murray (D-Wash.) Thursday introduced a budget amendment to promote the research, development, and approval or licensure of the "most cutting-edge, safe and effective medical treatments, devices, and cures for American patients and to ensure that America remains the global leader in biomedical innovation."  ... (click for more)

Cabela's To Open Fort Oglethorpe Store May 13

Cabela’s announced Monday plans to celebrate the official grand opening of its new Fort Oglethorpe store on Wednesday, May 13, with a unique ribbon-cutting ceremony followed by a weekend-long celebration featuring giveaways, family activities and more.  The ribbon-cutting ceremony, hosted by Cabela's executives and special guests, will begin at 9:45 a.m. and conclude with ... (click for more)

City Detective Who Was Arrested Twice In 4 Months Is Fired After Internal Affairs Investigation

A city detective who was arrested twice in four months has been fired by Police Chief Fred Fletcher. David Catchings had been charged with DUI last September and then with domestic assault at the end of the year. Police said, "After a complete review of both investigations – which included recommendations from Internal Affairs, the Administrative Review Committee and Officer ... (click for more)

Physicians Thank Their Patients On Doctor’s Day

March 30 has been set aside as National Doctors’ Day since 1933 as a time to recognize the contributions made by our physicians. While the recognition is appreciated, our greatest satisfaction comes from caring for our patients.  For 132 years, the Chattanooga-Hamilton County Medical Society has been the physicians’ voice as we worked together to improve health of our community. ... (click for more)

Roy Exum: The 15-Year-Old Marine

There are 58,267 names on the Vietnam Veterans Memorial Wall that today sits majestically in the Constitution Gardens of our nation's capital. It has never been lost on me that 33,103 of those who are named were only 18 years old when they died. But what caught my eye during my morning reading is that one of the names carved in the black granite “Dan Bullock“ was only 15 years old ... (click for more)